ARTICLE

FindCenter AddIcon

Here’s Everything to Know About Microdosing—Including How to Safely Do It

By Rebecca Norris — 2021

According to a 2019 survey-based study published in the Harm Reduction Journal, researchers found that microdosers experience a number of emotional, physical, and cognitive benefits. Emotionally, microdosers experienced an "improved outlook, appreciation of life, optimism, spiritual insights, and being more in touch with emotions." Cognitively, microdosers reported improved "focus and concentration, conscious awareness, mindfulness, and increased engagement and attentiveness." In other words, taking these small doses of drugs can be a real game-changer for many people.

Read on hellogiggles.com

FindCenter Post-Image

Study Suggests Cannabis Can Induce a Psychedelic-Like “Oceanic” Experience

Psychedelic drugs such as psilocybin and LSD can induce an experience known as oceanic boundlessness, which is characterized by a feeling of oneness with the world and a sense of awe.

Article
Eric W. Dolan
2021
FindCenter AddIcon
FindCenter Post-Image

Meet the Psychologist Using Psychedelics to Treat Racial Trauma

People of color are dealing with racism all the time, in large and small ways, and even dealing with racism in healthcare, even dealing with racism in therapy.

Article
Robin Donovan
2021
FindCenter AddIcon
FindCenter Post-Image

CIA Exploited Incarcerated Black Americans in Race for “Mind-Control” Agent

A well-kept American secret is that the CIA-funded research that exploited incarcerated Black Americans along with other vulnerable groups in America’s hunt for a “mind-control” drug.

Article
Dana Strauss, Monnica Williams
2021
FindCenter AddIcon
FindCenter Post-Image

The Cost of Exclusion in Psychedelic Research

In the last two decades, researchers have started to reexamine psychedelics for their therapeutic potential. Though initial results seem promising, the research has a significant shortcoming: the lack of racial and ethnic diversity among research teams and study participants.

Article
Xinyuan Chen, Mackenzie Bullard, Christy Duan, Jamilah R. George, Terence Ching, Stephanie Kilpatrick, Jordan Sloshower, Monnica Williams
2020
FindCenter AddIcon
FindCenter Post-Image

Psychedelic Psychotherapy Is Coming: Who Will Be Included?

A new study finds widespread exclusion of minorities in psychedelic research.

Article
Monnica T. Williams
2018
FindCenter AddIcon
FindCenter Post-Image

How Researchers and Advocates of Color Are Forging Their Own Paths in Psychedelic-Assisted Therapy

We’re seeing an explosion of medical research into psychedelics. Psilocybin, or shrooms, to treat major depressive disorder. Ayahuasca, a psychotropic plant medicine from the Amazon, and ibogaine, a potent hallucinogen from Africa, to treat addiction. LSD for anxiety.

Article
Steph Yin
2020
FindCenter AddIcon
FindCenter Post-Image

Study Finds Ketamine Can Help Patients Manage Depression and PTSD

Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.

Article
Hannah Sabourin
2021
FindCenter AddIcon
FindCenter Post-Image

Who Will Benefit From Psychedelic Medicine?

These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all.

Article
Whitney Joiner
2020
FindCenter AddIcon
FindCenter Post-Image

Psychedelics Shown to Ease the Effects of Racial Trauma

A recent study found that even a single positive psychedelic experience may ease mental health symptoms associated with racial trauma experienced by Black, Indigenous, and people of color (BIPOC).

Article
Kristi Pahr
2021
FindCenter AddIcon
FindCenter Post-Image

In a Traumatised World, is Psychedelic Therapy our Best Hope for Change?

Could there be one factor that links together conflict, climate change, racism, anxiety and eating disorders?

Article
Kate Thompson
FindCenter AddIcon

EXPLORE TOPIC

Microdosing